Accounts Payable and Related Party (Details Narrative) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Defined Benefit Plan Disclosure [Line Items] | ||
| Common stock, shares issued | 2,234,328 | 1,380,633 |
| Settled payables | $ 810,000 | $ 702,000 |
| gain on extinguishment | $ 547,000 | |
| Cytovance Biologics Inc [Member] | ||
| Defined Benefit Plan Disclosure [Line Items] | ||
| Common stock, shares issued | 127,597 | 57,437 |
| Accounts payable | $ 810,000 | $ 1,120,000 |
| Settled payables | 702,000 | |
| gain on extinguishment | $ 418,000 | |
| X | ||||||||||
- Definition Stock issued during period value common shares to settle vendor payable. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|